New osteoporosis drug safety checked in indian women

NCT ID NCT06079476

Completed Disease control Sponsor: Amgen Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested the safety of romosozumab (Evenity) in 100 postmenopausal women in India who have osteoporosis and a high risk of bone fractures. Researchers tracked side effects, serious events, and changes in lab tests and vital signs. They also measured bone density changes in the spine and hip. The goal was to see if the drug is safe and tolerable for this group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Romosozumab (Evenity)
What this could lead to: If successful, this could confirm that romosozumab is a safe option for treating osteoporosis and reducing fracture risk in postmenopausal women in India.
What could go wrong: This is a small, completed Phase 4 safety study, not designed to prove effectiveness. Results may not apply to other populations, and rare side effects may not be detected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTMENOPAUSAL OSTEOPOROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

osteoporosis postmenopausal osteoporosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POSTMENOPAUSAL OSTEOPOROSIS

Contacts and locations

Locations

Apollo Hospital

New Delhi, National Capital Territory of Delhi, 110076, India
Christain Medical College

Vellore, Tamil Nadu, 632004, India
King Edward Memorial Hospital And Seth Gordhandas Sunderdas Medical College

Mumbai, Maharashtra, 400012, India
King Georges Medical University

Lucknow, Uttar Pradesh, 226 003, India
MGM Healthcare

Chennai, Tamil Nadu, 600 029, India
MS Ramaiah Medical College and Hospitals

Bangalore, Karnataka, 560054, India
Post Graduate Institute of Medical Education and Research

Chandigarh, Punjab, 160 012, India
Sancheti Institute for Orthopedics and rehabilitation

Pune, Maharashtra, 411005, India
Sir Ganga Ram Hospital

New Delhi, National Capital Territory of Delhi, 110060, India
Stavya Spine Hospital and Research Institute SSHRI

Ahmedabad, Gujarat, 380 007, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.